Synthesis and Antiviral Evaluation of (1,4-Disubstituted-1,2,3-Triazol)-(


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
09 Mar 2021
Historique:
received: 16 02 2021
revised: 03 03 2021
accepted: 03 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 21 4 2021
Statut: epublish

Résumé

A series of hitherto unknown (1,4-disubstituted-1,2,3-triazol)-(

Identifiants

pubmed: 33803417
pii: molecules26051493
doi: 10.3390/molecules26051493
pmc: PMC7967160
pii:
doi:

Substances chimiques

Alkenes 0
Antiviral Agents 0
Azo Compounds 0
Nucleosides 0
Organophosphonates 0
Prodrugs 0
Triazoles 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH HHS
ID : P30AI050409
Pays : United States
Organisme : Laboratoire d'Excellence SYNORG
ID : ANR-11-LABX-0029

Références

J Org Chem. 2002 May 3;67(9):3057-64
pubmed: 11975567
J Virol. 2007 Apr;81(8):3992-4001
pubmed: 17267485
Bioorg Med Chem Lett. 2001 Apr 23;11(8):1053-6
pubmed: 11327587
Antiviral Res. 1994 Sep;25(1):1-11
pubmed: 7811057
Antimicrob Agents Chemother. 1998 Jul;42(7):1568-73
pubmed: 9660984
Chem Rev. 2009 Sep;109(9):4207-20
pubmed: 19737023
Antiviral Res. 2020 Sep;181:104869
pubmed: 32735901
Antimicrob Agents Chemother. 1990 Jun;34(6):1061-7
pubmed: 2393266
Antiviral Res. 2009 May;82(2):A84-98
pubmed: 19425198
J Pharm Sci. 1983 Mar;72(3):324-5
pubmed: 6842389
Antimicrob Agents Chemother. 1992 Nov;36(11):2423-31
pubmed: 1283296
Antimicrob Agents Chemother. 2002 Dec;46(12):3854-60
pubmed: 12435688
Top Curr Chem. 2015;360:115-60
pubmed: 25391982
J Med Chem. 2006 Nov 30;49(24):7215-26
pubmed: 17125274
Antimicrob Agents Chemother. 1997 Aug;41(8):1715-20
pubmed: 9257747
Adv Enzyme Regul. 1984;22:27-55
pubmed: 6382953
Angew Chem Int Ed Engl. 2002 Jul 15;41(14):2596-9
pubmed: 12203546
Nat Rev Drug Discov. 2005 Nov;4(11):928-40
pubmed: 16264436
Chemistry. 2010 May 10;16(18):5454-60
pubmed: 20373314
J Med Chem. 2011 Jan 13;54(1):222-32
pubmed: 21128666
Eur J Med Chem. 2018 Feb 25;146:678-686
pubmed: 29407990
Eur J Med Chem. 2013 Sep;67:398-408
pubmed: 23911854

Auteurs

Tuniyazi Abuduaini (T)

Institute of Organic and Analytical Chemistry, CNRS UMR 7311, Universite d'Orléans, F-45067 Orléans, France.

Vincent Roy (V)

Institute of Organic and Analytical Chemistry, CNRS UMR 7311, Universite d'Orléans, F-45067 Orléans, France.

Julien Marlet (J)

Inserm U1259, Université de Tours, 37032 Tours, France.

Catherine Gaudy-Graffin (C)

Inserm U1259, Université de Tours, 37032 Tours, France.

Denys Brand (D)

Inserm U1259, Université de Tours, 37032 Tours, France.

Cécile Baronti (C)

Unité des Virus Émergents (UVE: Aix-Marseille Univ, IRD 190, Inserm 1207, IHU Méditerranée Infection), 13000 Marseille, France.

Franck Touret (F)

Unité des Virus Émergents (UVE: Aix-Marseille Univ, IRD 190, Inserm 1207, IHU Méditerranée Infection), 13000 Marseille, France.

Bruno Coutard (B)

Unité des Virus Émergents (UVE: Aix-Marseille Univ, IRD 190, Inserm 1207, IHU Méditerranée Infection), 13000 Marseille, France.

Tamara R McBrayer (TR)

Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA 30222, USA.

Raymond F Schinazi (RF)

Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA 30222, USA.

Luigi A Agrofoglio (LA)

Institute of Organic and Analytical Chemistry, CNRS UMR 7311, Universite d'Orléans, F-45067 Orléans, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH